Buzrieda, A. (2021). Discovery of highly potent and selective phosphatidylinositol 3-kinase-δ inhibitors for the treatment of blood cancers and autoimmune diseases.
Chicago Style (17th ed.) CitationBuzrieda, Anas. Discovery of Highly Potent and Selective Phosphatidylinositol 3-kinase-δ Inhibitors for the Treatment of Blood Cancers and Autoimmune Diseases. 2021.
MLA (9th ed.) CitationBuzrieda, Anas. Discovery of Highly Potent and Selective Phosphatidylinositol 3-kinase-δ Inhibitors for the Treatment of Blood Cancers and Autoimmune Diseases. 2021.
Warning: These citations may not always be 100% accurate.